Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Groupe Hospitalier Paris Saint-Joseph is the First Hospital in France to License the Medworxx Clinical Criteria Module for Operational Use

C.RGX

Medworxx Solutions Inc. ("Medworxx") (TSX VENTURE:MWX), a leading healthcare patient flow software solutions provider, is pleased to announce that Groupe hospitalier Paris Saint-Joseph (St. Joseph) has selected Medworxx as their Patient Flow software provider. Located in the South of Paris, France, St. Joseph will implement the Medworxx Clinical Criteria module for 410 Medicine/ Surgery patient beds.

The hospital’s decision to implement the Medworxx solution for operational use comes as a result of conducting an Appropriate Length of Stay Audit (ALSA) with Medworxx Clinical Consultants in 2014. The goal of the ALSA was to analyze current patient flow metrics and review recommendations to improve patient flow. “After successfully testing the Medworxx solution, via the ALSA, and reviewing operational results from the UK and Canada, we see that the solution is highly effective in helping organizations to monitor, plan and implement process improvements. We believe it will be valuable at St. Joseph but also believe the solution is needed in the French Market at large, particularly in this challenging financial situation,” said Jean-Patrick Lajonchère, Directeur Général (CEO), Groupe hospitalier Paris Saint-Joseph.

“We now have operational use of the Medworxx solution in three distinct countries with three distinct health systems. We continue to prove that the Medworxx solution is applicable within International markets. The French market represents a large opportunity for Medworxx,” says Dan Matlow, President and CEO, Medworxx.

The Medworxx Clinical Criteria module will enable the hospital to identify the clinical appropriateness of each patient’s level of care, each day, and will provide clinicians with the ability to match patients with the right level of care, at the right time and in the most appropriate setting. The solution combines a unique methodology, process, communication, technology, and clinical information as a decision support tool for all levels of an organization. The Medworxx Patient Flow Platform provides hospitals with tools to bridge clinical and operational perspectives on daily patient flow –addressing issues of overcapacity, wait times and care coordination.

About the Groupe hospitalier Paris Saint-Joseph

  • Private charity hospital providing public medical attention and services (ESPIC, ex PSPH)
  • 612 beds of short term care
  • 5 clinical and medical technology centers
  • 1 Institute of Nursing Studies
  • V2010 certified by the Haute Autorité de Santé (HAS) in 2010
  • Ranked 44th in the top 50 of best hospitals in France (+300 beds) – Ranking by Le Point 2014
  • For more information, visit: www.hpsj.fr

About Medworxx
Medworxx delivers health information technology solutions to over 350 hospitals internationally, including Canada, United States, United Kingdom, France and Australia. Medworxx helps hospitals meet patient flow challenges and requirements for compliance and education. Medworxx Clinical Criteria —the flagship component of Medworxx Patient Flow, which also includes electronic bed management and independent assessment components— is currently used to manage 34% of the acute-care beds in Canada as well as acute-care beds in a rapidly increasing number of Trusts and CCGs in the UK. Founded in 2004, Medworxx Inc. is based in Toronto, Canada, and publicly traded on the TSX Venture Exchange: MWX. Visit: www.medworxx.com

Disclaimer
The statements made in this press release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the company’s expectations and projections. The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release.

Media Contact:
The Desk
Marine Dufour, 01 40 54 19 67
m.dufour@thedesk.fr
or
Medworxx
Dan Matlow, 416-642-1278 x311
President & Chief Executive Officer
1-800-321-1591
dmatlow@medworxx.com
www.medworxx.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today